| answer text |
<p>Defra is reviewing the F-gas Regulation, which includes an exemption from the hydrofluorocarbon
phasedown for metered dose inhalers (MDIs). The review will consider the implementation
of the current F-gas Regulation and options for future policy development. The implications
of removing the exemption for MDIs, including the potential impact of this on cost
and supply, will be included in the analysis.</p><p> </p><p>NHS England is in the
process of reducing the use of MDIs containing high global warming potential propellants
and has produced cost estimates for the switch from MDIs to currently readily available
alternatives. These cost estimates will be incorporated in Defra’s work.</p><p> </p><p>Defra
is working on this review jointly with the Scottish and Welsh Governments and we plan
to consult on proposed future policies next year.</p>
|
 |
